โ Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
โน๏ธ Info
๐งพ At a Glance ๐ Core Facts ๐๏ธ Products/Services โญ Ratings ๐งโ๐ผ Executives ๐ฌ My Comments๐ก Analytics
๐ Insights ๐ข Company Q&A (464) ๐ ๏ธ Industry Q&A (98) ๐ Competitors ๐ Price Low ๐ Price Swings โก SWOT ๐๏ธ PEST ๐ Porter's Five Forces โจ Score Positive โ ๏ธ Risk Assessment ๐งฉ Segmentation ๐ ถ Google Links๐ Ratios
๐ฐ Margins ๐ Financial Ratios ๐ฑ Growth ๐ Enterprise Value ๐ Key Metrics ๐ต Dividends๐ง Tools
โ Due Diligence๐ข Press Releases
Date | Press release |
---|---|
2025-05-07 07:30:00 | Cardinal Health Releases New Report On The Cell And Gene Therapy Industry Analysis charts the emergence and future of advanced therapies dublin, ohio , may 7, 2025 /prnewswire/ -- today, cardinal health (nyse: cah) released its 2025 advanced therapies report: revolutionizing patient care โ the promise and potential of cell and gene therapies, providing insights into the evolving landscape of cell and gene therapies (cgts). this inaugural report is based on a comprehensive survey of more than 100 healthcare providers as well as interviews with subject matter experts and a patient who received car t-cell therapy, all of whom provide valuable insights into the state of the cgt industry. |
2025-05-05 17:30:00 | Cardinal Health Board Of Directors Approves Quarterly Dividend Dublin, ohio , may 5, 2025 /prnewswire/ -- cardinal health (nyse: cah) announced today that its board of directors approved an increase to its quarterly dividend, to $0.5107 per share, out of the companyโs capital surplus. the dividend will be payable on july 15, 2025, to shareholders of record at the close of business on july 1, 2025. |
2025-05-01 06:45:00 | Cardinal Health Reports Third Quarter Fiscal Year 2025 Results And Raises Fiscal Year 2025 Outlook Revenue was flat at $54.9 billion; revenue increased 19% excluding the impact of the previously communicated customer contract expiration gaap 1 operating earnings were $730 million; gaap diluted eps was $2.10 non-gaap operating earnings increased 21% to $807 million, driven by segment profit growth across all of the companyโs operating segments; non-gaap diluted eps increased 13% to $2.35 fiscal year 2025 non-gaap eps guidance2 raised and narrowed to $8.05 to $8.15, from $7.85 to $8.00 gi alliance announces expansion into urology specialty therapeutic area dublin, ohio , may 1, 2025 /prnewswire/ -- cardinal health (nyse:ย cah) today reported third quarter fiscal year 2025 revenues of $54.9 billion, flat to the third quarter of fiscal year 2024. third quarter revenue increased 19% excluding the impact of the previously communicated customer contract expiration. |
2025-04-08 06:30:00 | Telix Announces Cardinal Health For Gozellix Commercial Distribution Melbourne, australia and indianapolis, april 08, 2025 (globe newswire) -- telix pharmaceuticals limited (asx: tlx, nasdaq: tlx, telix, the company) today announces that it has selected cardinal health, inc. (nyse: cah, cardinal health) as one of its commercial radiopharmaceutical distributors to supply finished unit doses of gozellixยฎ (kit for the preparation of gallium-68 (68ga) gozetotide injection), telixโs next-generation psma-pet imaging1 agent for prostate cancer in the united states (u.s.). |
2025-03-25 06:45:00 | Cardinal Health To Announce Third-quarter Results For Fiscal Year 2025 On May 1 Dublin, ohio , march 25, 2025 /prnewswire/ -- cardinal health (nyse: cah) plans to release third-quarter financial results for its fiscal year 2025 on may 1, prior to the opening of trading on the new york stock exchange. the company will webcast a discussion of these results beginning at 8:30 a.m. |
2025-03-10 06:45:00 |
|
2025-02-03 17:15:00 |
|
2025-01-30 06:45:00 |
|
2025-01-14 10:00:00 |
|
2024-12-30 04:13:00 |
|
2024-12-19 06:45:00 |
|
2024-11-20 07:30:00 |
|
2024-11-11 21:21:00 |
|
2024-11-11 20:42:00 |
|
2024-11-05 17:15:00 |
|

๐ฐ Browse additional press releases for Cardinal Health!
Sign up for free or log in๐ Unlock our free guide: "The Checklist Value Investor โ A Smarter Way to Pick Stocks"